Climb Bio Inc: Baird assumes coverage with outperform rating; target price $21
CLYM•Related News
US declares end of largest recorded cyclosporiasis outbreak
XLY•
Nasdaq trade halt continues PLTS.O reason not available at 07:50 PM
PLTS•
DocuSign director Peter Solvik disposes of USD 3,004,020 in common shares
DOCU•
Cove Point LNG Terminal To Begin Scheduled Maintenance On Sept 14
D•
Nasdaq Trade Halt <HUBC.O> Halt News Pending at 07:50 PM
HUBC•